news
Discovery could lead to targeted melanoma therapies
18 June 2015 | By Victoria White
Melanoma patients with high levels of a protein that controls the expression of pro-growth genes are less likely to survive, according to a new study...
List view / Grid view
Gene testing
Gene testing is a type of medical test that identifies changes in chromosomes, genes, or proteins.
news
ImmunoGen’s IMGN529 demonstrates synergistic activity with rituximab in preclinical models of non-hodgkin lymphoma
18 June 2015 | By Victoria White
Findings from ImmunoGen’s preclinical assessments of IMGN529 in combination with rituximab have been presented at ICML 2015...
news
ALK1 protein may play a role in breast cancer metastasis
15 June 2015 | By Victoria White
Scientists from Lund University have discovered that expression of ALK1 is significantly associated with the incidence of breast cancer metastasis...
news
New compound that represses the PPARy protein could be potential treatment for osteoporosis
12 June 2015 | By Victoria White
Researchers combined a variety of structural biology approaches to rationally design a new compound that could repress the biological activity of PPARy...
news
Scientists uncover the unique role of BDNF neurons in the body’s use of energy
12 June 2015 | By Victoria White
Scientists have discovered the roles of two distinct types of BDNF neurons - those that control appetite or satiety and those that control thermogenesis...
news
Mutated TCF12 gene linked to aggressive form of brain cancer
12 June 2015 | By Victoria White
Scientists have identified that errors in a gene known as TCF12 are associated with more aggressive forms of a disease called anaplastic oligodendroglioma...
news
Discovery gives hope for finding a treatment for amyotrophic lateral sclerosis
10 June 2015 | By Victoria White
A previously unknown link between the immune system and the death of motor neurons in amyotrophic lateral sclerosis has been discovered by scientists...
article
Stem cells discoveries: Arming scientists with the tools they need
10 June 2015 | By Molecular Devices
Molecular Devices discusses stem cells research and the company’s latest technological advancements in this exciting field...
article
Academic drug discovery in neurodegeneration; a new approach to an ageing problem
Dementia is a global crisis with 76 million people worldwide expected to be living with the condition by 2030. Current symptomatic treatments provide modest improvements in cognition but disease-modifying therapies for diseases like Alzheimer’s – the most common cause of dementia – do not yet exist.
news
FDA and EMA grants orphan drug designation to recAP for the treatment of hypophosphatasia
9 June 2015 | By Victoria White
AM‐Pharma has announced that the FDA and EMA have both granted orphan designation status to recAP for the treatment of hypophosphatasia...
news
Myxoma virus kills cancer cells while blocking graft-versus-host disease in bone marrow transplants
8 June 2015 | By Victoria White
Researchers have discovered that the myxoma virus can kill some kinds of cancer cells while eliminating a complication of bone marrow transplants...
news
TSRI chemists devise inexpensive method for synthesising amines
26 May 2015 | By Victoria White
Chemists at The Scripps Research Institute (TSRI) have discovered a broad and strikingly inexpensive method for synthesising amines...
news
Scientists unveil ‘Rosetta Stone’ of prostate cancer
21 May 2015 | By Victoria White
Almost 90% of men with advanced prostate cancer carry genetic mutations in their tumours that could be targeted by either existing or new cancer drugs...
news
Positive preclinical results support the development of ISTH0036 for the treatment of glaucoma
11 May 2015 | By Victoria White
Isarna Therapeutics presented preclinical data for its lead candidate ISTH0036 in one podium presentation and two poster publications at ARVO 2015...
news
MabVax Therapeutics’ HuMab 5B1 antibody successfully clears important early toxicology testing
6 May 2015 | By Victoria White
The final report on toxicology testing of HuMab 5B1 shows that it had no significant adverse findings even at the highest dosage levels tested...
